- Home
- EVGO vs CADL Comparison
EVGO vs CADL Comparison
Compare EVGO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- CADL
- Stock Information
- Founded
- EVGO 2010
- CADL 1999
- Country
- EVGO United States
- CADL United States
- Employees
- EVGO N/A
- CADL N/A
- Industry
- EVGO Other Specialty Stores
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- CADL Health Care
- Exchange
- EVGO Nasdaq
- CADL Nasdaq
- Market Cap
- EVGO 376.5M
- CADL 234.8M
- IPO Year
- EVGO N/A
- CADL 2021
- Fundamental
- Price
- EVGO $3.83
- CADL $4.76
- Analyst Decision
- EVGO Strong Buy
- CADL Strong Buy
- Analyst Count
- EVGO 10
- CADL 4
- Target Price
- EVGO $5.78
- CADL $21.00
- AVG Volume (30 Days)
- EVGO 3.9M
- CADL 864.6K
- Earning Date
- EVGO 05-06-2025
- CADL 05-13-2025
- Dividend Yield
- EVGO N/A
- CADL N/A
- EPS Growth
- EVGO N/A
- CADL N/A
- EPS
- EVGO N/A
- CADL N/A
- Revenue
- EVGO $276,954,000.00
- CADL N/A
- Revenue This Year
- EVGO $39.82
- CADL N/A
- Revenue Next Year
- EVGO $32.12
- CADL N/A
- P/E Ratio
- EVGO N/A
- CADL N/A
- Revenue Growth
- EVGO 45.15
- CADL N/A
- 52 Week Low
- EVGO $1.78
- CADL $3.79
- 52 Week High
- EVGO $9.07
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EVGO 79.08
- CADL 41.42
- Support Level
- EVGO $2.66
- CADL $4.80
- Resistance Level
- EVGO $4.17
- CADL $5.34
- Average True Range (ATR)
- EVGO 0.23
- CADL 0.33
- MACD
- EVGO 0.13
- CADL 0.10
- Stochastic Oscillator
- EVGO 81.13
- CADL 42.09
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.